Guest account
Sign in to access your account
$84.95
Half-life
~192 hours
Purity
≥ 99.8%
Mw
4,563 g/mol
In stock
A next-generation dual GLP-1R/GCGR agonist (oxyntomodulin analog) for advanced metabolic, weight management, and obesity/diabetes research. Promotes potent appetite suppression, energy expenditure, fat metabolism, and glycemic control. Long-acting with lipid conjugation for weekly dosing.
Mechanism of action
Mazdutide is a dual agonist of the GLP-1 receptor (GLP-1R) and glucagon receptor (GCGR), modeled on oxyntomodulin (OXM). GLP-1R activation: Glucose-dependent insulin secretion, suppression of glucagon, delayed gastric emptying, increased satiety, and reduced appetite/ food intake. GCGR activation: Increased energy expenditure, lipolysis, hepatic fat metabolism, and thermogenesis (counterbalanced by GLP-1R to avoid hyperglycemia).
Lyophilized: −20°C, 24 months. Post-reconstitution: 4°C, 30 days.
Add 2 mL BAC water slowly along vial wall. Swirl gently. Allow 5–10 min.
Identity + purity
Identity + purity
USP <71> compliant
Full COA ships with every order including HPLC trace, mass spec, and per-batch purity percentage.